A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
This study is ongoing, but not recruiting participants.
Sponsor:
Northwestern University
Collaborator:
Bayer
Information provided by (Responsible Party):
Northwestern University
ClinicalTrials.gov Identifier:
NCT00858117
First received: March 6, 2009
Last updated: March 19, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |